ZEB2 siRNA (h) from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) Silencing ZEB2 Induces Apoptosis and Reduces Viability in Glioblastoma Cell LinesMolecules (Basel, Switzerland)February 9, 2021Safaee S, Fardi M, Hemmat N, Khosravi N, Derakhshani A, Silvestris N, Baradaran B.

(3) Impact of miR-192 and miR-194 on cyst enlargement through EMT in autosomal dominant polycystic kidney diseaseFASEB journal : official publication of the Federation of American Societies for Experimental BiologyFebruary 1, 2019Kim DY, Woo YM, Lee S, Oh S, Shin Y, Shin JO, Park EY, Ko JY, Lee EJ, Bok J, et al.

(4) Effect of ZEB2 silencing on cisplatin resistance in gastric cancerEuropean review for medical and pharmacological sciencesApril 1, 2017Geng DM, Kan XM, Zhang WW.

(5) Integrated long non-coding RNA analyses identify novel regulators of epithelial-mesenchymal transition in the mouse model of pulmonary fibrosisJournal of cellular and molecular medicineJuly 1, 2016Sun H, Chen J, Qian W, Kang J, Wang J, Jiang L, Qiao L, Chen W, Zhang J.morphology. For small‐interference RNA (siRNA) transfection, cells were transfected with ZEB2 siRNA (Cat. #: sc‐38641; Santa Cruz Biotechnology) using Lipofectamine 2000 according to the manufacturer's protocol. Statistical

(6) MicroRNA-129-5p modulates epithelial-to-mesenchymal transition by targeting SIP1 and SOX4 during peritoneal dialysisLaboratory investigation; a journal of technical methods and pathologyJuly 1, 2015Xiao L, Zhou X, Liu F, Hu C, Zhu X, Luo Y, Wang M, Xu X, Yang S, Kanwar YS, et al.

(9) Genome-wide profiling of AP-1-regulated transcription provides insights into the invasiveness of triple-negative breast cancerCancer researchJuly 15, 2014Zhao C, Qiao Y, Jonsson P, Wang J, Xu L, Rouhi P, Sinha I, Cao Y, Williams C, Dahlman-Wright K.

ZEB2 siRNA (h)